QualityStocksNewsBreaks Archives - Page 857 of 1457

TuesdayDec 01, 2020 9:00 am

QualityStocksNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Appointment of New VP of Translational Medicine

VistaGen Therapeutics (NASDAQ: VTGN) has appointed a new vice president of translational medicine. A pioneer in the development of neuroactive steroids known as pherines, Louis Monti, MD., PhD., developed the original scientific platform that enabled the early research and development of VistaGen's PH94B and PH10. The two intranasal neuroactive steroid drug candidates (pherines) have potential for the rapid-onset treatment of anxiety and depression disorders, respectively. VistaGen is a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders. Throughout…

MondayNov 30, 2020 3:23 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Enters Strategic Agreement for Expansion into EU Market

Brain Scientific’s (OTCQB: BRSF) Vice President of Marketing, Stuart Bernstein, has written an article for Health Care Business News titled, “COVID's influence on neurology drives need for disposable technologies.” The piece discusses increased concern for health care and frontline workers treating emergent cases for COVID-19 patients developing neurological symptoms and conditions, as well as a critical need for testing solutions. The article reads, “Sudden onset of seizures, metabolic encephalopathy, stroke and other neurological conditions can negatively impact COVID patient outcomes and morbidity rates. Growing evidence of the commonality of neurological symptoms in COVID patients, coupled with challenges in accessibility, efficiency…

MondayNov 30, 2020 3:04 pm

QualityStocksNewsBreaks – Appreciated Media Holdings Inc. (TSXV: AMH) (OTCQB: AMEFF) Announces Changes to Management, Board Structure, Enters into Forbearance Agreement

Appreciated Media Holdings (TSXV: AMH) (OTCQB: AMEFF) on Thursday announced the resignation of Douglass Magallon and Gregory Strom as directors of the corporation effective Nov. 13, 2020, as well as expiry of the forbearance period granted pursuant to the forbearance agreement, as amended and supplemented, between the corporation and Amcomri GP BVI Limited, previously disclosed Aug. 17, 2020. In addition, Appreciated Media on Friday announced that its board of directors has negotiated a forbearance agreement with Amcomri GP BVI Limited until January 5, 2020. As a condition to the receipt of forbearance, the board has approved a reorganization of the…

MondayNov 30, 2020 1:35 pm

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Featured in SNN Network Interview

Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced that it was featured in a new video interview with SNN Network, “The Official Small-, Micro- and Nano-Cap News Source(TM).” According to the update, Jupiter Wellness CEO Brian John and chairman and Chief Scientific Officer Dr. Glynn Wilson joined SNN host Robert Kraft to discuss the company’s focus on proprietary patent/patent-pending CBD sun and skin care brands. “We wanted to focus this company on our own proprietary patented or patent-pending products, and that’s really what Jupiter Wellness was built around. We have four…

MondayNov 30, 2020 1:04 pm

QualityStocksNewsBreaks – Knightscope Inc. Secures Many New Patents

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), recently announced its award of eight patents. The patents cover the company’s Autonomous Data Machines and Systems (“ADMs”) (U.S. Patent Nos. 9,329,597, 9,910,436, 10,279,488 and 10,579,060), the security data analysis and display features of the KSOC (U.S. Patent Nos. 9,792,434 and 10,514,837) and its parking monitor feature (U.S. Patent Nos. 9,773,413 and 10,311,731). Knightscope has additionally filed one provisional patent covering the ADMs’ behavioral autonomous technology. The company, as it gains more experience (now having operated over 1 million hours in the field), expects to stream…

MondayNov 30, 2020 12:21 pm

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Enters Strategic Agreement with CB Auto Group

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), a fintech provider disrupting the automotive industry, today announced that, upon receipt of final acceptance from the TSX Venture Exchange, it has executed a common voting stock purchase agreement to acquire up to 15% of CB Auto Group, Inc.'s issued and outstanding common shares for aggregate consideration of USD $5,000,000. Under the agreement, CB Auto's over 67 million members will be directed to DRIVRZ(TM) when looking to acquire new or used vehicles. Additionally, PowerBand will be able to market DRIVRZ, along with associated services and products, exclusively to that membership. "I'm delighted…

MondayNov 30, 2020 11:56 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6) Issues Commentary on IIROC-Imposed Trading Halt

Clean Power (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6) on Thursday issued a news release to comment on the stock halt on the Frankfurt Exchange and IIROC-imposed trading halt, both on Nov. 24, 2020. According to the update, the company provided clarification on certain statements made in a paid promotional newsletter in Germany about the company’s investment in PowerTap Hydrogen Fueling Corp. The newsletter was published pursuant to the consulting agreement, initially disclosed on Oct. 28, 2020, between the company and First Marketing GmbH (“FMG”), an investor relations and marketing firm based in Heidelberg, Germany, to provide marketing services focused on…

MondayNov 30, 2020 10:57 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Advancement of MS1819 Combination Therapy Trial in Turkey

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that the first two patients have been dosed in Turkey for its Phase 2 trial. The trial evaluates its investigational drug, MS1819, in combination with the current standard of care, porcine-derived pancreatic enzyme replacement therapy (“PERT”), for the treatment of severe exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis (“CF”). “In the midst of a global pandemic and unpredictable obstacles, we are very encouraged to see our combination therapy trial moving forward at one of the clinical testing sites in Turkey,”…

MondayNov 30, 2020 10:38 am

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) to Begin Trading Under Nasdaq Ticker Symbol “WRAP”

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced that its Nasdaq ticker symbol is set to change from “WRTC” to “WRAP” beginning at market open on Tuesday, December 1, 2020. “We are excited to align the new ticker symbol ‘WRAP’ directly to our corporate brand and strengthen our visibility with public investors while providing consistent brand recognition across all stakeholders,” Wrap Technologies President and Interim CEO Tom Smith stated in the news release. “We are protecting our WRAP(R) and BolaWrap(R) brands in 50 countries as our brand recognition continues to increase worldwide. The recent change of…

MondayNov 30, 2020 10:07 am

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) Advances Move into Field of Mushroom Extractions

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sectors, on Thursday provided an update and overview regarding its expansion into the functional mushroom wellness sector. According to the update, interest is climbing sharply in functional and medicinal mushrooms, particularly regarding medicinal opportunities. Pure Extracts noted increased institutional interest in the field of psychedelics in general and with a focus on promising mushroom varieties such as psilocybin specifically. As a result of the encouraging and growing interest in the sector, Pure Extracts has commenced the expansion of its…

Site Search

Company Search

Category: QualityStocksNewsBreaks